By the end of this year, 867 government health facilities in South Africa will start offering the two-monthly HIV prevention injection, CAB-LA, using 96,000 doses donated by the US government. This injection, which gradually releases the antiretroviral drug cabotegravir over two months, has been shown to virtually eliminate the risk of contracting HIV through sexual intercourse. A 2022 study published…